Scientists test new cancer drug's hidden effects on heart and diabetes pills

This early-stage study tested whether an experimental cancer drug called zongertinib changes how the body processes other common medications. Researchers gave 32 healthy men zongertinib along with drugs like a blood thinner (dabigatran), a cholesterol pill (rosuvastatin), a diabetes drug (metformin), and a water pill (furosemide). They measured drug levels in the blood to see if zongertinib made these other medications stronger, weaker, or stayed the same.